NewAmsterdam Pharma Co NV

FRA:KH6 (Netherlands)  
€ 20.20 (+1%) Mar 28
At Loss
P/B:
6.55
Market Cap:
€ 1.95B ($ 2.11B)
Enterprise V:
€ 1.64B ($ 1.77B)
Volume:
-
Avg Vol (2M):
75.00
Also Trade In:

Business Description

Description
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
Name Current Vs Industry Vs History
Cash-To-Debt 5674.17
Equity-to-Asset 0.83
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 18.89
Distress
Grey
Safe
Beneish M-Score -1.46
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -52.6
3-Year EPS without NRI Growth Rate -48.1
3-Year FCF Growth Rate -36.8

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 70.75
9-Day RSI 59.27
14-Day RSI 56.97
6-1 Month Momentum % 157.31
12-1 Month Momentum % 78.86

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.95
Quick Ratio 6.95
Cash Ratio 6.82
Days Sales Outstanding 3111.9

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -95.9

Financials (Next Earnings Date:2024-05-08 Est.)

FRA:KH6's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

NewAmsterdam Pharma Co NV Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 12.983
EPS (TTM) (€) -1.978
Beta 0
Volatility % 100.36
14-Day RSI 56.97
14-Day ATR (€) 0.921648
20-Day SMA (€) 19.645
12-1 Month Momentum % 78.86
52-Week Range (€) 5.4 - 22.8
Shares Outstanding (Mil) 89.27

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

NewAmsterdam Pharma Co NV Filings

Filing Date Document Date Form
No Filing Data

NewAmsterdam Pharma Co NV Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

NewAmsterdam Pharma Co NV Frequently Asked Questions

What is NewAmsterdam Pharma Co NV(FRA:KH6)'s stock price today?
The current price of FRA:KH6 is €20.20. The 52 week high of FRA:KH6 is €22.80 and 52 week low is €5.40.
When is next earnings date of NewAmsterdam Pharma Co NV(FRA:KH6)?
The next earnings date of NewAmsterdam Pharma Co NV(FRA:KH6) is 2024-05-08 Est..
Does NewAmsterdam Pharma Co NV(FRA:KH6) pay dividends? If so, how much?
NewAmsterdam Pharma Co NV(FRA:KH6) does not pay dividend.

Press Release

Subject Date
No Press Release